Anthracycline-Induced Cardiotoxicity

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 6, Iss. 4, 2008-10 ,pp. : 278-281

Bentham Science Publishers

Access to resources Recommend Favorite

Genotyping the risk of anthracycline-induced cardiotoxicity

By Deng Shiwei   Wojnowski Leszek  

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 129-134

Humana Press, Inc

Access to resources Recommend Favorite

Oxidant-induced inhibition of myocardial calcium-independent phospholipase A₂

By McHowat Jane   Swift Luther   Sarvazyan Narine  

Cardiovascular Toxicology, Vol. 1, Iss. 4, 2001-12 ,pp. : 309-316

Humana Press, Inc

Access to resources Recommend Favorite

New iron chelators in anthracycline-induced cardiotoxicity

By Kaiserová Helena   Šimůnek Tomáš   Štěrba Martin   Hartog Gertjan   Schröterová Ladislava   Popelová Olga   Geršl Vladimír   Kvasničková Eva   Bast Aalt  

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 145-150

Humana Press, Inc

Access to resources Recommend Favorite

Inhibition of secretory phospholipase A₂ activity attenuates lipopolysaccharide-induced acute lung injury in a mouse model

By Sato Ryota   Yamaga Satoshi   Watanabe Kazuyoshi   Hishiyama Sensuke   Kawabata Ken-ichi   Kobayashi Tsuyoshi   Fujioka Daisuke   Saito Yukio   Yano Toshiaki   Watanabe Kazuhiro   Watanabe Yosuke   Ishihara Hiroshi   Kugiyama Kiyotaka  

Experimental Lung Research, Vol. 36, Iss. 4, 2010-04 ,pp. : 191-200

Informa Healthcare

Access to resources Recommend Favorite